DUBLIN--(BUSINESS WIRE)--Aug 7, 2018--The "Global Anti-snoring Treatment Market - Segmented by Treatment Technique and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

The global anti-snoring treatment market is expected to register a CAGR of about 7.5% during the forecast period, 2018-2023.

Increasing obesity and a rise in geriatric population are some of the primary factors driving the demand for the anti-snoring treatment market. According to the World Health Organization (WHO), the obese population tripled between 1975 and 2016. WHO also states that, in 2016, more than 1.9 billion adults were overweight and over 650 million were in the obese category. Among children, more than 40 million below the age of five were overweight or obese. Snoring is highest among the population aging between 40 to 60 years old.

The social stigma associated with snoring is among the major factors hindering the usage of these of devices and surgical equipment in certain regions. Both, male and female population are affected by traditional prejudices and it often leads to sleep apnea remaining undiagnosed for years. In many cases, patients are incorrectly diagnosed with other indications, such as menopausal changes, anemia, diabetes, hypertension, and depression among others.

The Asia-Pacific region has a large diversified patient population, improving healthcare infrastructure, and countries with high economic growth in past few years, such as India and China. The Asia-Pacific region is dominated by private hospitals, community healthcare, home healthcare, and sleep clinics. As per the WHO, Australia, Thailand, Malaysia, and South Korea are the countries with high obese and overweight population, and India and Vietnam are among the least.

Companies Mentioned

Accumed Corp Apnea Sciences Fisher & Paykel Healthcare Limited Koninklijke Philips Nv Meditas Resmed Somnomed The Pure Sleep Company Tomed Gmbh Whole You Inc.

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/26sth8/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180807005370/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Medical Devices

KEYWORD: ASIA PACIFIC

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/07/2018 06:06 AM/DISC: 08/07/2018 06:06 AM

http://www.businesswire.com/news/home/20180807005370/en